Suppliers / Kilitch Drugs (India)

Kilitch Drugs (India)

India 305 employees 2 duplicate records merged Updated 9 July 2026

Kilitch Drugs (India) is a finished-dose manufacturer based in India. It appears in 71 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with EFDA (ET), NAFDAC (NG) and EEC_EAEU. Its GMP standing is certified by NAFDAC (NG), CDSCO (India) and FDA (GH). Customs aggregates show $15.7M of exports covering 575 molecules to 26 destinations in 2025.

0
active US DMFs
0
valid CEPs
3
registered plants
71
filings across 5 regulators

Registered plants

Site FDA FEI
hodiyar colonylakhabavad 361 006jamnagar, India Not on file
Survey No, India Not on file
Navi Mumbai, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EFDA (ET) 57 None
NAFDAC (NG) 10 2
EEC_EAEU 2 None
MCAZ (ZW) 1 None
DIGEMAPS (DO) 1 None
CDSCO (India) None 2
FDA (GH) None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $4.1M 16
2025 Not reported $15.7M 26
2024 Not reported $15.1M 30
2023 Not reported $14.7M 27

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Kilitch Drugs (India) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts